.jpg)
- Clinical & Translational Oncology
-
影響因子：
1.276
-
I S S N：
1699-048X
-
出 版 社：
Springer
-
出 版 地：
Milan : Springer Italia
-
出版國(guó)家：
Italy
-
刊 期：
月刊
-
創(chuàng)刊時(shí)間：
2005
-
語(yǔ) 種：
英文
-
審稿周期：
平均2.2月
-
中科院分區(qū)：
4
-
投稿命中率：
命中率約50%
-
國(guó)外數(shù)據(jù)庫(kù)收錄：
IM
-
中國(guó)收錄文章數(shù)：
60
-
5年影響因子：
1.316
-
研究領(lǐng)域：
腫瘤
-
官方鏈接：
http://link.springer.com/journal/12094
-
投稿須知：
http://link.springer.com/journal/12094
期刊介紹：
Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of biomarkers for cancer diagnosis, prognosis or prediction of treatment response, identification of new targets for cancer therapy, as well as development of new technologies for research and treatment of cancer are the major themes covered by both the educational series and research articles. A broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
